MOLECULAR MECHANISM OF T LYMPHOCYTE ACTIVATION

T淋巴细胞激活的分子机制

基本信息

  • 批准号:
    3748256
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Perturbation of the T cell receptor (TCR)/CD3 complex by antigen (in the context of the appropriate MHC) or by anti-receptor antibodies (Ab) initiates a cascade of events which includes protein tyrosine kinase activation, tyr osine phosphorylation of an inositol phospholipid (InsPL)-specific phospholipase C (PLC) isozyme, PLC gamma-1 , activation of InsPL hydrolysis, and the generation of second messengers that control protein kinase C activation and calcium mobilization. The objective of this study is to elucidate the mechanism coupling PLC gamma-1 to the TCR/CD3 complex and regulating its activity and effector function. A number of functional subdomains constitutes PLC gamma-1. Some of these domains are homologous to amino acid modules initially defined in the src gene product. These src-homology domains (SH) function as docking sites in protein/protein interactions: SH2 recognizes tyrosine phosphorylated peptides, while SH3 interacts with proline-rich sequences of certain proteins. PLC gamma-1 contains two SH2 and one SH3, whose function is currently unknown. We have expressed both SH2 and the SH3 of PLC gamma-1 (individually or in combination) as fusion proteins (FP) with the glutathione S-transferase (GST) from S. iaponicum. By screening with an anti-phosphotyrosine (PY) Ab, at least two phosphoproteins were detected by coprecipitation with the carboxy-terminal SH2 from lysates of activated human Jurkat T leukemia cells or a mouse T lymphocyte cell line. One distinct phosphoprotein was recognized by the GST-SH3. No detectable phosphoprotein was precipitated with the NH2-terminal SH2 or from non-activated cells. Additive but not synergistic effects on phosphoprotein recruitment was observed with the GST-FP encompassing multiple SH domains. The phosphoprotein recognized by the GST-SH3 was identified by immunoreactivity as c-cbl, a transcription factor. Although cbl phosphorylation was activation-dependent, its interaction with GST- SH3 was not. An additional non-phosphorylated protein coprecipitated with GST-SH3 and competed with cbl for SH3 binding. Identification of this protein and the GST-SH2-precipitated proteins is in progress. Additional PLC gamma-1 subdomains are also tested for their role in protein recruitment and PLC regulation.
抗原对T细胞受体(TCR)/CD 3复合物的扰动(在免疫组化中) 适当的MHC的背景)或抗受体抗体(Ab) 启动包括蛋白酪氨酸激酶在内的级联反应 肌醇磷脂的酪氨酸磷酸化活化 (InsPL)特异性磷脂酶C(PLC)同工酶,PLC γ-1,活化 的InsPL水解,并产生第二信使,控制 蛋白激酶C激活和钙动员。的目标 本研究旨在阐明PLC γ-1与 TCR/CD 3复合物及其活性和效应功能的调节。一 许多功能亚结构域构成PLC γ-1。其中一些 结构域与src中最初定义的氨基酸模块同源 基因产物这些src同源结构域(SH)作为对接位点发挥功能 在蛋白质/蛋白质相互作用中:SH 2识别酪氨酸磷酸化 肽,而SH 3与某些富含脯氨酸的序列相互作用, proteins. PLC gamma-1包含两个SH 2和一个SH 3,其功能是 目前未知。我们表达了PLC γ-1的SH 2和SH 3, (单独或组合)作为与 谷胱甘肽S-转移酶(GST)。Iaponicum。通过筛选, 抗磷酸酪氨酸(PY)抗体,至少检测到两种磷蛋白 通过与来自以下的裂解物的羧基末端SH 2共沉淀, 活化的人Jurkat T白血病细胞或小鼠T淋巴细胞 线一个独特的磷蛋白被GST-SH 3识别。没有 可检测的磷蛋白与NH 2-末端SH 2或 非活化细胞。 相加而非协同效应 在GST-FP中观察到磷蛋白募集, 多个SH结构域。GST-SH 3识别的磷蛋白是 通过免疫反应性鉴定为c-cbl,一种转录因子。虽然 cbl磷酸化是激活依赖性的,它与GST- SH 3没有。一种额外的非磷酸化蛋白质与 GST-SH 3,并与cbl竞争SH 3结合。鉴定此 蛋白质和GST-SH 2沉淀蛋白质正在进行中。额外 还测试了PLC γ-1亚结构域在蛋白质中的作用。 招聘和PLC监管。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

E BONVINI其他文献

E BONVINI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('E BONVINI', 18)}}的其他基金

MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLCR1 ACTIVATION
T淋巴细胞激活机制--PLCR1激活的调控
  • 批准号:
    2569028
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLC GAMMA1 ACTIVATION
T淋巴细胞激活机制--PLC GAMMA1激活的调控
  • 批准号:
    6101290
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ROLE OF G-PROTEINS IN THE CONTROL OF INOSITOL PHOSPHOLIPID HYDROLYSIS IN T-CELLS
G 蛋白在控制 T 细胞中肌醇磷脂水解中的作用
  • 批准号:
    3811105
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
SIGNAL TRANSDUCTION VIA THE T CELL RECEPTOR /CD3 COMPLEX
通过 T 细胞受体 /CD3 复合物进行信号转导
  • 批准号:
    3804896
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR MECHANISM OF T LYMPHOCYTE ACTIVATION
T淋巴细胞激活的分子机制
  • 批准号:
    5200811
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR MECHANISMS OF T-LYMPHOCYTE ACTIVATION
T 淋巴细胞激活的分子机制
  • 批准号:
    3792639
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANALYSIS OF INOSITOL PHOSPHATE METABOLISM IN T LYMPHOCYTES BY HPLC
HPLC分析磷酸肌醇在T淋巴细胞中的代谢
  • 批准号:
    3811108
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISM OF T LYMPHOCYTE ACTIVATION--REGULATION OF PLC GAMMA1 ACTIVATION
T淋巴细胞激活机制--PLC GAMMA1激活的调控
  • 批准号:
    6161348
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了